The Professional Society for Health Economics and Outcomes Research 2024

ISPOR 2024 - 国际药物经济学与结果研究学会年会 2024
The Professional Society for Health Economics and Outcomes Research 2024

2024/05/05 - 2024/05/08

美国 · 亚特兰大

共3条结果

疾病标签 (field_disease_tag)

材料类型 (field_material_type)

会议壁报

Cost-of-Care Comparison of Elranatamab-bcmm and Teclistamab-cqyv in Adult Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Shah B, Sandin R, Liu Y, et al

ISPOR 2024 - 国际药物经济学与结果研究学会年会 2024 | 肿瘤 | 血液肿瘤 | 易瑞欧

会议壁报

Budget Impact of Elranatamab in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) in the United States

Shah B, Sandin R, Liu Y, et al

ISPOR 2024 - 国际药物经济学与结果研究学会年会 2024 | 肿瘤 | 血液肿瘤 | 易瑞欧

会议壁报

Patient and Oncologist Preferences for TKIs in First-Line Treatment of ALK+ Advanced NSCLC: Commonalities and Disconnects

Le H, Coulter J, Cappelleri JC, et al

ISPOR 2024 - 国际药物经济学与结果研究学会年会 2024 | 肿瘤 | 肺癌 | 赛可瑞